Skip to main content
. 2017 Mar 30;4(8):1600491. doi: 10.1002/advs.201600491

Figure 4.

Figure 4

F127‐HEPI‐MP nanocomplexs robustly expand in tumor tissue, where they reduce residual disease and relapse. a) Longitudinal in vivo bioluminescence imaging of U87 cells retrovirally transduced with m‐Cherry. b) mCherry‐luc signal intensities after implant transfer; each line represents a group (control, HEPI‐EP, or F127‐HPEI‐MP). c) Kaplan–Meier curves of animal survival following 3D conformal gene therapy.